Skip to main content
. 2019 Sep 13;75(6):843–852. doi: 10.1111/his.13952

Figure 4.

Figure 4

A, Microdissected clear cell chondrosarcoma area used for next‐generation sequencing (NGS). B, NGS showing the presence of the IDH1 c.395G>T, p.Arg132Leu mutation (allele frequency: 0.03). C, Microdissected conventional chondrosarcoma area used for NGS. D, NGS showing the presence of an identical IDH1 c.395G>T, p.Arg132Leu mutation (allele frequency: 0.29) (case 1). Scale bar: 250 μm (A,C).